Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2462-2468
Published online before print August 17, 2006, doi: 10.1161/01.ATV.0000242013.29441.81
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/11/2462    most recent
01.ATV.0000242013.29441.81v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, V. Y.
Right arrow Articles by Kroetz, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, V. Y.
Right arrow Articles by Kroetz, D. L.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:2462.)
© 2006 American Heart Association, Inc.


Vascular Biology

Inhibition of Smooth Muscle Proliferation by Urea-Based Alkanoic Acids via Peroxisome Proliferator-Activated Receptor {alpha}–Dependent Repression of Cyclin D1

Valerie Y. Ng; Christophe Morisseau; John R. Falck; Bruce D. Hammock; Deanna L. Kroetz

From the Department of Biopharmaceutical Sciences (V.Y.N., D.L.K.), the Center for Human Genetics (D.L.K.), and the Liver Center (D.L.K.), University of California, San Francisco; Department of Entomology and the Cancer Research Center (C.M., B.D.H), University of California, Davis; and Department of Biochemistry (J.R.F.), University of Texas Southwestern Medical Center, Dallas.

Correspondence to Deanna L. Kroetz, PhD, Department of Biopharmaceutical Sciences, University of California San Francisco, 1550 4th St, Box 2911, San Francisco, CA 94143-2911. E-mail deanna.kroetz{at}ucsf.edu

Objective— Proliferation of smooth muscle cells is implicated in cardiovascular complications. Previously, a urea-based soluble epoxide hydrolase inhibitor was shown to attenuate smooth muscle cell proliferation. We examined the possibility that urea-based alkanoic acids activate the nuclear receptor peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}) and the role of PPAR{alpha} in smooth muscle cell proliferation.

Methods and Results— Alkanoic acids transactivated PPAR{alpha}, induced binding of PPAR{alpha} to its response element, and significantly induced the expression of PPAR{alpha}-responsive genes, showing their function as PPAR{alpha} agonists. Furthermore, the alkanoic acids attenuated platelet-derived growth factor–induced smooth muscle cell proliferation via repression of cyclin D1 expression. Using small interfering RNA to decrease endogenous PPAR{alpha} expression, it was determined that PPAR{alpha} was partially involved in the cyclin D1 repression. The antiproliferative effects of alkanoic acids may also be attributed to their inhibitory effects on soluble epoxide hydrolase, because epoxyeicosatrienoic acids alone inhibited smooth muscle cell proliferation.

Conclusions— These results show that attenuation of smooth muscle cell proliferation by urea-based alkanoic acids is mediated, in part, by the activation of PPAR{alpha}. These acids may be useful for designing therapeutics to treat diseases characterized by excessive smooth muscle cell proliferation.

Proliferation of smooth muscle cells is implicated in cardiovascular complications. Urea-based alkanoic acids are identified as agonists of the nuclear receptor peroxisome proliferator-activated receptor {alpha} (PPAR{alpha}). These acids attenuate smooth muscle cell proliferation, in part by decreasing cyclin D1 via PPAR{alpha} activation.


Key Words: soluble expoxide hydrolase • epoxyeicosatrienoic acids • PPAR{alpha} • smooth muscle cells • proliferation




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
A. N. Simpkins, R. D. Rudic, D. A. Schreihofer, S. Roy, M. Manhiani, H.-J. Tsai, B. D. Hammock, and J. D. Imig
Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection
Am. J. Pathol., June 1, 2009; 174(6): 2086 - 2095.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. A. Spector
Arachidonic acid cytochrome P450 epoxygenase pathway
J. Lipid Res., April 1, 2009; 50(Supplement): S52 - S56.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
V. Y. Ng, Y. Huang, L. M. Reddy, J. R. Falck, E. T. Lin, and D. L. Kroetz
Cytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor {alpha}
Drug Metab. Dispos., July 1, 2007; 35(7): 1126 - 1134.
[Abstract] [Full Text] [PDF]